Xalipmin Film-coated tablets
PDF Leaflet Revision Date: 25 July 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Indicated for hypercholesterolemia and cardiovascular risk reduction.
Dosage (summary)
Starting dose is 10 mg once daily, max 80 mg depending on indication.
Onset of Action / Duration
Onset: 2 weeks, Duration: 4 weeks for max response.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- CYP3A4 inhibitors
- Gemfibrozil
- Fusidic acid
Contraindications
- Hypersensitivity to atorvastatin
- Active liver disease
- Pregnancy
- Breastfeeding
Common side effects
- Myalgia
- Headache
- Constipation
- Hyperglycemia
Counselling Points
- Report muscle pain or weakness
- Avoid grapefruit juice
- Use contraception if of childbearing potential
Serious warnings
- Risk of myopathy and rhabdomyolysis
- Liver function monitoring required
Important Disclaimer
The Xalipmin Film-coated tablets professional information leaflet below is the property of Trinity Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
